Creating a new rapid test for diagnosing Chagas disease
Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease
['FUNDING_SBIR_2'] · INBIOS INTERNATIONAL, INC. · NIH-11086142
This study is working on a new, quick test called Chagas Detect PlusTM to help find Chagas disease in people who might not show any symptoms, so they can get treated sooner and avoid serious health issues later on.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INBIOS INTERNATIONAL, INC. (nih funded) |
| Locations | 1 site (Seattle, UNITED STATES) |
| Trial ID | NIH-11086142 on ClinicalTrials.gov |
What this research studies
This research focuses on developing an advanced rapid test called Chagas Detect PlusTM that aims to accurately diagnose Chagas disease, which is caused by the Trypanosoma cruzi parasite. The project seeks to enhance the sensitivity and specificity of the test to ensure that it can effectively identify asymptomatic individuals who may be infected. By optimizing the test's performance and preparing it for FDA clearance, the research aims to make this diagnostic tool widely available for use in both the US and globally. This could lead to earlier treatment for those infected, reducing the risk of severe health complications later on.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from regions where Chagas disease is prevalent, particularly those who may be asymptomatic but at risk of infection.
Not a fit: Patients who are not at risk for Chagas disease or those who have already been diagnosed and treated may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a highly accurate and accessible test for Chagas disease, enabling early diagnosis and treatment.
How similar studies have performed: Previous research has shown success in developing rapid tests for other infectious diseases, indicating potential for this approach in Chagas disease diagnostics.
Where this research is happening
Seattle, UNITED STATES
- INBIOS INTERNATIONAL, INC. — Seattle, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RAYCHAUDHURI, SYAMAL X — INBIOS INTERNATIONAL, INC.
- Study coordinator: RAYCHAUDHURI, SYAMAL X
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: acute infection, Cardiac Diseases, Cardiac Disorders